Capital International Investors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,113,749
| Closed | -$11.7M | – | 458 |
|
|
2024
Q1 | $11.7M | Hold |
3,113,749
| – | – | ﹤0.01% | 395 |
|
|
2023
Q4 | $30.5M | Hold |
3,113,749
| – | – | 0.01% | 358 |
|
|
2023
Q3 | $26M | Sell |
3,113,749
-1,102,052
| -26% | -$9.2M | 0.01% | 361 |
|
|
2023
Q2 | $56.1M | Hold |
4,215,801
| – | – | 0.01% | 330 |
|
|
2023
Q1 | $48.8M | Sell |
4,215,801
-1,883,880
| -31% | -$21.8M | 0.01% | 339 |
|
|
2022
Q4 | $49.9M | Sell |
6,099,681
-2,349,477
| -28% | -$19.2M | 0.01% | 327 |
|
|
2022
Q3 | $49M | Sell |
8,449,158
-3,126,338
| -27% | -$18.1M | 0.01% | 336 |
|
|
2022
Q2 | $51.2M | Sell |
11,575,496
-1,206,359
| -9% | -$5.33M | 0.01% | 345 |
|
|
2022
Q1 | $116M | Buy |
12,781,855
+675,537
| +6% | +$6.15M | 0.03% | 294 |
|
|
2021
Q4 | $248M | Buy |
12,106,318
+712,191
| +6% | +$14.6M | 0.05% | 249 |
|
|
2021
Q3 | $291M | Buy |
11,394,127
+2,616,823
| +30% | +$66.9M | 0.07% | 225 |
|
|
2021
Q2 | $307M | Buy |
8,777,304
+840,179
| +11% | +$29.4M | 0.07% | 213 |
|
|
2021
Q1 | $264M | Sell |
7,937,125
-1,870,901
| -19% | -$62.3M | 0.07% | 215 |
|
|
2020
Q4 | $254M | Sell |
9,808,026
-931,806
| -9% | -$24.2M | 0.07% | 215 |
|
|
2020
Q3 | $106M | Buy |
10,739,832
+3,943,532
| +58% | +$38.9M | 0.03% | 262 |
|
|
2020
Q2 | $23.4M | Hold |
6,796,300
| – | – | 0.01% | 346 |
|
|
2020
Q1 | $20.8M | Buy |
6,796,300
+1,514,500
| +29% | +$4.63M | 0.01% | 318 |
|
|
2019
Q4 | $27.1M | Buy |
+5,281,800
| New | +$27.1M | 0.01% | 301 |
|
|
2019
Q1 | – | Sell |
-2,080,000
| Closed | -$15.4M | – | 391 |
|
|
2018
Q4 | $15.4M | Sell |
2,080,000
-2,082,441
| -50% | -$15.4M | 0.01% | 322 |
|
|
2018
Q3 | $22.5M | Buy |
+4,162,441
| New | +$22.5M | 0.01% | 320 |
|